drugset / Trial / NCT00788827

Autologous Adult Stem Cells to Patients With Type 1 Diabetes and a Successful Renal Transplant

NCT00788827 ↗

Phase 1 Completed 7 enrolled Imperial College London
NaSingle-groupOpen-labelTreatment

Summary

This is a phase I study to assess the safety and tolerability of infusing expanded stem cells into the pancreas of patients with type I diabetes and a successful renal transplant. The stem cells used in this study occur naturally in the body and are collected from each recipient by a procedure called leukapheresis. The cells are then expanded and differentiated into insulin-like cells in a sterile suite before being injected into the body or tail of the pancreas of the recipient.

Timeline

Start
2008-11
Primary completion
2013-05
Completion
2013-05

Drugs

EvaluationDrugModalityDoseRoute
Subject Autologous CD34+ stem cells Cell therapy 5e+08 cells Other